ERBB2 and breast carcinoma: These results suggest an association of HER2 status with levels of Firmicutes among those with age at menarche at ≥ 12 (p = 0.027), and a borderline association of age at menarche with Firmicutes among women with HER2− breast cancer (p = 0.105).